Colgate-Palmolive Company $CL Shares Sold by US Bancorp DE

US Bancorp DE cut its position in Colgate-Palmolive Company (NYSE:CL) by 4.1% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 336,793 shares of the company’s stock after selling 14,529 shares during the period. US Bancorp DE’s holdings in Colgate-Palmolive were worth $26,923,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the business. Tiemann Investment Advisors LLC increased its stake in shares of Colgate-Palmolive by 2.1% in the second quarter. Tiemann Investment Advisors LLC now owns 6,083 shares of the company’s stock worth $553,000 after acquiring an additional 125 shares during the period. Westside Investment Management Inc. grew its position in Colgate-Palmolive by 85.5% during the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock worth $26,000 after purchasing an additional 130 shares during the period. S.A. Mason LLC raised its stake in shares of Colgate-Palmolive by 3.9% during the 3rd quarter. S.A. Mason LLC now owns 3,499 shares of the company’s stock valued at $280,000 after buying an additional 130 shares during the last quarter. Security National Bank of Sioux City Iowa IA boosted its stake in shares of Colgate-Palmolive by 0.8% in the third quarter. Security National Bank of Sioux City Iowa IA now owns 16,241 shares of the company’s stock worth $1,298,000 after buying an additional 130 shares during the last quarter. Finally, Stratos Wealth Advisors LLC grew its holdings in Colgate-Palmolive by 4.5% during the third quarter. Stratos Wealth Advisors LLC now owns 3,015 shares of the company’s stock worth $241,000 after acquiring an additional 130 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, insider Sally Massey sold 15,851 shares of the company’s stock in a transaction that occurred on Thursday, February 5th. The stock was sold at an average price of $95.03, for a total value of $1,506,320.53. Following the transaction, the insider directly owned 13,751 shares in the company, valued at approximately $1,306,757.53. This represents a 53.55% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO Panagiotis Tsourapas sold 15,000 shares of the stock in a transaction that occurred on Thursday, February 12th. The stock was sold at an average price of $97.81, for a total value of $1,467,150.00. Following the completion of the transaction, the chief operating officer owned 10,415 shares of the company’s stock, valued at $1,018,691.15. The trade was a 59.02% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 184,683 shares of company stock valued at $17,486,693 in the last ninety days. 0.34% of the stock is currently owned by company insiders.

Analyst Ratings Changes

CL has been the topic of a number of analyst reports. Rothschild & Co Redburn set a $93.00 price objective on shares of Colgate-Palmolive in a research note on Friday, February 13th. UBS Group raised their target price on Colgate-Palmolive from $90.00 to $93.00 and gave the company a “buy” rating in a research report on Wednesday, January 14th. Piper Sandler upped their target price on Colgate-Palmolive from $88.00 to $96.00 and gave the stock an “overweight” rating in a research note on Friday, January 30th. Barclays upped their price objective on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 3rd. Finally, Wells Fargo & Company lifted their target price on shares of Colgate-Palmolive from $86.00 to $94.00 and gave the company an “equal weight” rating in a research report on Sunday, February 1st. Eleven investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $94.75.

Colgate-Palmolive Trading Up 1.5%

CL opened at $99.01 on Friday. The firm has a market capitalization of $79.81 billion, a price-to-earnings ratio of 37.79, a price-to-earnings-growth ratio of 4.40 and a beta of 0.29. The company’s 50 day simple moving average is $87.49 and its two-hundred day simple moving average is $82.73. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $100.18. The company has a debt-to-equity ratio of 18.82, a current ratio of 0.83 and a quick ratio of 0.27.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, January 30th. The company reported $0.95 EPS for the quarter, beating the consensus estimate of $0.91 by $0.04. The firm had revenue of $5.23 billion during the quarter, compared to analysts’ expectations of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The business’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter last year, the firm earned $0.91 earnings per share. Analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, February 13th. Investors of record on Wednesday, January 21st were issued a $0.52 dividend. The ex-dividend date of this dividend was Wednesday, January 21st. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.1%. Colgate-Palmolive’s dividend payout ratio is currently 79.39%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.